Advertisement
Advertisement

IMTX

IMTX logo

Immatics N.V. Ordinary Shares

9.53
USD
Sponsored
+0.15
+1.61%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

9.54

+0.01
+0.09%

IMTX Earnings Reports

Positive Surprise Ratio

IMTX beat 10 of 22 last estimates.

45%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.87M
/
-$0.38
Implied change from Q3 25 (Revenue/ EPS)
+90.37%
/
-9.52%
Implied change from Q4 24 (Revenue/ EPS)
-82.45%
/
-188.37%

Immatics N.V. Ordinary Shares earnings per share and revenue

On Nov 17, 2025, IMTX reported earnings of -0.42 USD per share (EPS) for Q3 25, missing the estimate of -0.39 USD, resulting in a -5.58% surprise. Revenue reached 5.19 million, compared to an expected 10.87 million, with a -52.27% difference. The market reacted with a -7.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 9.87 million USD, implying an decrease of -9.52% EPS, and increase of 90.37% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Immatics N.V. Ordinary Shares reported EPS of -$0.42, missing estimates by -5.58%, and revenue of $5.19M, -52.27% below expectations.
The stock price moved down -7.16%, changed from $10.20 before the earnings release to $9.47 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 11 analysts, Immatics N.V. Ordinary Shares is expected to report EPS of -$0.38 and revenue of $9.87M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement